Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
166 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Rank Status Study
21 Recruiting PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)
Conditions: Hematological Malignancies;   Thrombocytopenia
Interventions: Drug: EACA;   Other: Platelet transfusion
22 Recruiting Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Condition: Isolated Chemotherapy-induced Thrombocytopenia
Intervention: Biological: romiplostim
23 Recruiting Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Primary Thrombocytopenia,Unspecified;   Thrombocytopenia Chemotherapy Induced
Intervention: Biological: Transfusion of Pooled Platelets Cryopreserved In DMSO
24 Recruiting A Rollover Study to Provide Continued Treatment With Eltrombopag
Condition: Thrombocytopaenia
Intervention: Drug: ELT
25 Recruiting Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Condition: Thrombocytopenia
Intervention: Drug: Eltrombopag
26 Recruiting A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
27 Not yet recruiting Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Condition: Neonatal Alloimmune Thrombocytopenia
Intervention: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
28 Recruiting Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition: Neonatal Thrombocytopenia
Intervention:
29 Recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
30 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
31 Not yet recruiting Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing
Condition: Cytopenia
Intervention: Procedure: Bone Marrow Aspirate
32 Recruiting Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
Conditions: Thrombotic Microangiopathy;   Disorder Related to Bone Marrow Transplantation
Intervention: Drug: eculizumab
33 Not yet recruiting Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)
Condition: Thrombotic Microangiopathies
Intervention: Biological: Technozyme
34 Available OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy
Condition: Thrombotic Microangiopathy
Intervention: Biological: OMS721
35 Recruiting Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
Condition: Thrombotic Microangiopathies
Intervention: Biological: OMS721
36 Recruiting Molecular Biology of Polycythemia and Thrombocytosis
Conditions: Polycythemia;   Thrombocytosis
Intervention:
37 Recruiting Observational Trial of a Therapeutic Platelet Transfusion Regimen
Conditions: Acute Myeloid Leukemia;   Thrombocytopenia
Intervention:
38 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Conditions: Antineoplastic Adverse Reaction;   Thrombocytopenia;   Acute Myelocytic Leukemia
Intervention: Drug: rhTPO
39 Recruiting TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
Conditions: Hematologic Neoplasms;   Hemorrhage;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Tranexamic acid (TXA).;   Drug: Placebo
40 Not yet recruiting 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms
Conditions: Essential Thrombocythemia;   Primary Myelofibrosis, Fibrotic Stage;   Primary Myelofibrosis, Prefibrotic Stage;   Polycythemia Vera
Intervention: Device: Diagnostic (18F-FLT PET/CT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.